This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chou, S Articles by Sewell, D L Search for Related Content PubMed PubMed Citation Articles by Chou, S Articles by Sewell, D L

 Previous Article  |  Next Article 

J Clin Microbiol. 1987 January; 25(1): 52-55

Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.

ABSTRACT

Two commercially available enzyme immunoassays and one assembled in house were used to measure immunoglobulin M (IgM) antibody to cytomegalovirus (CMV) in a total of 220 serum specimens from 104 renal transplant recipients. All assays included a step in which interfering IgG antibody was removed or complexed. Concordance of results between pairs of assays ranged from 84 to 96%. All sera from patients with recent seroconversion (primary CMV infection) had measurable anti-CMV IgM. Among those already seropositive to CMV when transplanted, 26 to 55% had IgM antibody posttransplant, depending on the assay. This was observed regardless of the CMV serologic status of the kidney donor, indicating that reactivation of endogenous CMV, as well as reinfection, can induce this antibody in transplant recipients. Four cadaver donors known to transmit CMV to eight recipients did not have measurable IgM antibody to CMV.

This article has been cited by other articles:

• Bantug, G. R. B., Cekinovic, D., Bradford, R., Koontz, T., Jonjic, S., Britt, W. J. (2008). CD8+ T Lymphocytes Control Murine Cytomegalovirus Replication in the Central Nervous System of Newborn Animals. J. Immunol. 181: 2111-2123 [Abstract] [Full Text]